Catalyst Pharmaceuticals (CPRX) Return on Sales [ROS] (2018 - 2026)
Catalyst Pharmaceuticals (CPRX) reported Return on Sales [ROS] of 49.02% for Q1 2026, up 4.21 percentage points from 44.81% a year earlier and up 8.50 percentage points from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) Return on Sales [ROS] (2018 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Catalyst Pharmaceuticals' Return on Sales [ROS] came in at 44.83%, up 1.56 percentage points year-over-year; for FY2025, it was 43.77%, up 4.09 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +9.08 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at 39.68% in FY2024 (+17.88 pp), 21.80% in FY2023 (-25.74 pp), 47.54% in FY2022 (+10.35 pp) and 37.20% in FY2021 (+2.51 pp).
- The Q1 2026 figure ranks as the highest quarterly Return on Sales [ROS] since Q4 2022.
- Year over year, Return on Sales [ROS] gained in six of the last eight quarters, with an average year-over-year change of +12.94 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q3 2024 (a gain of 75.77 percentage points); the low point was Q3 2023 (a drop of 80.07 percentage points).
- Per Business Quant data, the three quarters before Q1 2026 came in at 40.52% (Q4 2025), 44.66% (Q3 2025) and 45.24% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 49.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 49.02% |
| Dec 31, 2025 | 40.52% |
| Sep 30, 2025 | 44.66% |
| Jun 30, 2025 | 45.24% |
| Mar 31, 2025 | 44.81% |
| Dec 31, 2024 | 44.31% |
| Sep 30, 2024 | 39.56% |
| Jun 30, 2024 | 44.21% |
| Mar 31, 2024 | 27.54% |
| Dec 31, 2023 | 37.71% |
| Sep 30, 2023 | -36.21% |
| Jun 30, 2023 | 46.90% |
| Mar 31, 2023 | 41.71% |
| Dec 31, 2022 | 50.70% |
| Sep 30, 2022 | 43.85% |
| Jun 30, 2022 | 53.79% |
| Mar 31, 2022 | 40.30% |
| Dec 31, 2021 | 33.26% |
| Sep 30, 2021 | 38.95% |
| Jun 30, 2021 | 43.55% |
API Access
Catalyst Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();